nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluticasone Propionate—CYP3A4—Temozolomide—melanoma	0.129	0.285	CbGbCtD
Fluticasone Propionate—CYP3A7—Docetaxel—melanoma	0.083	0.183	CbGbCtD
Fluticasone Propionate—CYP3A7-CYP3A51P—Docetaxel—melanoma	0.083	0.183	CbGbCtD
Fluticasone Propionate—CYP3A4—Vemurafenib—melanoma	0.0708	0.156	CbGbCtD
Fluticasone Propionate—CYP3A5—Docetaxel—melanoma	0.0623	0.138	CbGbCtD
Fluticasone Propionate—Common wart—Vemurafenib—melanoma	0.0274	0.0846	CcSEcCtD
Fluticasone Propionate—CYP3A4—Docetaxel—melanoma	0.0243	0.0537	CbGbCtD
Fluticasone Propionate—Hyperadrenocorticism—Temozolomide—melanoma	0.0131	0.0406	CcSEcCtD
Fluticasone Propionate—Skin papilloma—Vemurafenib—melanoma	0.0122	0.0377	CcSEcCtD
Fluticasone Propionate—Growth retardation—Dactinomycin—melanoma	0.0099	0.0306	CcSEcCtD
Fluticasone Propionate—Cushing's syndrome—Carmustine—melanoma	0.00926	0.0286	CcSEcCtD
Fluticasone Propionate—Skin striae—Bleomycin—melanoma	0.00758	0.0234	CcSEcCtD
Fluticasone Propionate—Folliculitis—Vemurafenib—melanoma	0.00633	0.0195	CcSEcCtD
Fluticasone Propionate—Cutaneous hypersensitivity—Docetaxel—melanoma	0.00553	0.0171	CcSEcCtD
Fluticasone Propionate—Lower respiratory tract infection—Docetaxel—melanoma	0.00396	0.0122	CcSEcCtD
Fluticasone Propionate—Folliculitis—Dactinomycin—melanoma	0.00357	0.011	CcSEcCtD
Fluticasone Propionate—Oral candidiasis—Carmustine—melanoma	0.00331	0.0102	CcSEcCtD
Fluticasone Propionate—Oral candidiasis—Temozolomide—melanoma	0.0032	0.00988	CcSEcCtD
Fluticasone Propionate—Atrial fibrillation—Vemurafenib—melanoma	0.00305	0.0094	CcSEcCtD
Fluticasone Propionate—Influenza-like symptoms—Temozolomide—melanoma	0.00284	0.00878	CcSEcCtD
Fluticasone Propionate—Endocrine disorder—Temozolomide—melanoma	0.00245	0.00757	CcSEcCtD
Fluticasone Propionate—Wheezing—Bleomycin—melanoma	0.00234	0.00722	CcSEcCtD
Fluticasone Propionate—Lacrimation—Docetaxel—melanoma	0.0023	0.0071	CcSEcCtD
Fluticasone Propionate—Viral infection—Temozolomide—melanoma	0.00225	0.00695	CcSEcCtD
Fluticasone Propionate—Infestation—Vemurafenib—melanoma	0.00222	0.00687	CcSEcCtD
Fluticasone Propionate—Infestation NOS—Vemurafenib—melanoma	0.00222	0.00687	CcSEcCtD
Fluticasone Propionate—Herpes simplex—Temozolomide—melanoma	0.0022	0.00681	CcSEcCtD
Fluticasone Propionate—Oral candidiasis—Docetaxel—melanoma	0.00213	0.00657	CcSEcCtD
Fluticasone Propionate—Supraventricular tachycardia—Docetaxel—melanoma	0.00206	0.00637	CcSEcCtD
Fluticasone Propionate—Candida infection—Carmustine—melanoma	0.00201	0.0062	CcSEcCtD
Fluticasone Propionate—Influenza like illness—Temozolomide—melanoma	0.00197	0.00609	CcSEcCtD
Fluticasone Propionate—Connective tissue disorder—Vemurafenib—melanoma	0.00196	0.00606	CcSEcCtD
Fluticasone Propionate—Candida infection—Temozolomide—melanoma	0.00194	0.00599	CcSEcCtD
Fluticasone Propionate—Throat sore—Docetaxel—melanoma	0.00187	0.00579	CcSEcCtD
Fluticasone Propionate—Eye disorder—Vemurafenib—melanoma	0.00187	0.00576	CcSEcCtD
Fluticasone Propionate—Oropharyngeal discomfort—Docetaxel—melanoma	0.00186	0.00574	CcSEcCtD
Fluticasone Propionate—Cardiac disorder—Vemurafenib—melanoma	0.00185	0.00572	CcSEcCtD
Fluticasone Propionate—Dermatitis atopic—Docetaxel—melanoma	0.00183	0.00564	CcSEcCtD
Fluticasone Propionate—Mediastinal disorder—Vemurafenib—melanoma	0.0018	0.00556	CcSEcCtD
Fluticasone Propionate—Rash erythematous—Docetaxel—melanoma	0.00176	0.00545	CcSEcCtD
Fluticasone Propionate—Diabetes mellitus—Carmustine—melanoma	0.00175	0.00542	CcSEcCtD
Fluticasone Propionate—Erythema—Vemurafenib—melanoma	0.00174	0.00537	CcSEcCtD
Fluticasone Propionate—Malnutrition—Vemurafenib—melanoma	0.00174	0.00537	CcSEcCtD
Fluticasone Propionate—Rhinorrhoea—Docetaxel—melanoma	0.00167	0.00515	CcSEcCtD
Fluticasone Propionate—Ageusia—Docetaxel—melanoma	0.00167	0.00515	CcSEcCtD
Fluticasone Propionate—Nasal congestion—Temozolomide—melanoma	0.00162	0.005	CcSEcCtD
Fluticasone Propionate—Eye irritation—Docetaxel—melanoma	0.00158	0.00489	CcSEcCtD
Fluticasone Propionate—Cough—Vemurafenib—melanoma	0.00152	0.00468	CcSEcCtD
Fluticasone Propionate—Bronchospasm—Bleomycin—melanoma	0.00149	0.00459	CcSEcCtD
Fluticasone Propionate—Oropharyngeal pain—Docetaxel—melanoma	0.00149	0.00459	CcSEcCtD
Fluticasone Propionate—Arthralgia—Vemurafenib—melanoma	0.00148	0.00457	CcSEcCtD
Fluticasone Propionate—Face oedema—Carmustine—melanoma	0.00147	0.00455	CcSEcCtD
Fluticasone Propionate—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—melanoma	0.00147	0.00454	CcSEcCtD
Fluticasone Propionate—Lacrimation increased—Docetaxel—melanoma	0.00147	0.00453	CcSEcCtD
Fluticasone Propionate—Face oedema—Temozolomide—melanoma	0.00142	0.0044	CcSEcCtD
Fluticasone Propionate—Anaphylactic shock—Vemurafenib—melanoma	0.00142	0.00438	CcSEcCtD
Fluticasone Propionate—Infection—Vemurafenib—melanoma	0.00141	0.00435	CcSEcCtD
Fluticasone Propionate—Nervous system disorder—Vemurafenib—melanoma	0.00139	0.0043	CcSEcCtD
Fluticasone Propionate—Skin disorder—Vemurafenib—melanoma	0.00138	0.00425	CcSEcCtD
Fluticasone Propionate—Pneumonia—Bleomycin—melanoma	0.00136	0.00419	CcSEcCtD
Fluticasone Propionate—Influenza like illness—Docetaxel—melanoma	0.00131	0.00405	CcSEcCtD
Fluticasone Propionate—Musculoskeletal discomfort—Vemurafenib—melanoma	0.00129	0.00399	CcSEcCtD
Fluticasone Propionate—Candida infection—Docetaxel—melanoma	0.00129	0.00398	CcSEcCtD
Fluticasone Propionate—Abdominal distension—Temozolomide—melanoma	0.00128	0.00396	CcSEcCtD
Fluticasone Propionate—Pneumonia—Dactinomycin—melanoma	0.00126	0.0039	CcSEcCtD
Fluticasone Propionate—Bronchitis—Temozolomide—melanoma	0.00123	0.00379	CcSEcCtD
Fluticasone Propionate—Lightheadedness—Docetaxel—melanoma	0.00121	0.00373	CcSEcCtD
Fluticasone Propionate—Hypoaesthesia—Bleomycin—melanoma	0.0012	0.00372	CcSEcCtD
Fluticasone Propionate—Hyperglycaemia—Carmustine—melanoma	0.00119	0.00367	CcSEcCtD
Fluticasone Propionate—Upper respiratory tract infection—Temozolomide—melanoma	0.00118	0.00366	CcSEcCtD
Fluticasone Propionate—Pneumonia—Carmustine—melanoma	0.00118	0.00365	CcSEcCtD
Fluticasone Propionate—Hyperglycaemia—Temozolomide—melanoma	0.00115	0.00355	CcSEcCtD
Fluticasone Propionate—Pneumonia—Temozolomide—melanoma	0.00114	0.00353	CcSEcCtD
Fluticasone Propionate—Infestation—Temozolomide—melanoma	0.00114	0.00351	CcSEcCtD
Fluticasone Propionate—Infestation NOS—Temozolomide—melanoma	0.00114	0.00351	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Vemurafenib—melanoma	0.00112	0.00346	CcSEcCtD
Fluticasone Propionate—Pharyngitis—Dactinomycin—melanoma	0.00112	0.00346	CcSEcCtD
Fluticasone Propionate—Sinusitis—Temozolomide—melanoma	0.00107	0.00329	CcSEcCtD
Fluticasone Propionate—Erythema—Bleomycin—melanoma	0.00105	0.00325	CcSEcCtD
Fluticasone Propionate—Hypoaesthesia—Carmustine—melanoma	0.00105	0.00324	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Vemurafenib—melanoma	0.00105	0.00323	CcSEcCtD
Fluticasone Propionate—Connective tissue disorder—Carmustine—melanoma	0.00104	0.0032	CcSEcCtD
Fluticasone Propionate—Atrial fibrillation—Docetaxel—melanoma	0.00104	0.0032	CcSEcCtD
Fluticasone Propionate—Dermatitis bullous—Docetaxel—melanoma	0.00103	0.00317	CcSEcCtD
Fluticasone Propionate—Hypoaesthesia—Temozolomide—melanoma	0.00102	0.00314	CcSEcCtD
Fluticasone Propionate—Pharyngitis—Temozolomide—melanoma	0.00101	0.00313	CcSEcCtD
Fluticasone Propionate—Pruritus—Vemurafenib—melanoma	0.001	0.0031	CcSEcCtD
Fluticasone Propionate—Connective tissue disorder—Temozolomide—melanoma	0.001	0.0031	CcSEcCtD
Fluticasone Propionate—Eye disorder—Carmustine—melanoma	0.000987	0.00305	CcSEcCtD
Fluticasone Propionate—Erythema—Dactinomycin—melanoma	0.000982	0.00303	CcSEcCtD
Fluticasone Propionate—Ill-defined disorder—Bleomycin—melanoma	0.000977	0.00302	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Vemurafenib—melanoma	0.000971	0.003	CcSEcCtD
Fluticasone Propionate—Eye disorder—Temozolomide—melanoma	0.000954	0.00294	CcSEcCtD
Fluticasone Propionate—Malaise—Bleomycin—melanoma	0.00095	0.00293	CcSEcCtD
Fluticasone Propionate—Cardiac disorder—Temozolomide—melanoma	0.000947	0.00292	CcSEcCtD
Fluticasone Propionate—Arrhythmia—Carmustine—melanoma	0.000943	0.00291	CcSEcCtD
Fluticasone Propionate—Dizziness—Vemurafenib—melanoma	0.000938	0.0029	CcSEcCtD
Fluticasone Propionate—Mental disorder—Carmustine—melanoma	0.000925	0.00286	CcSEcCtD
Fluticasone Propionate—Immune system disorder—Temozolomide—melanoma	0.000922	0.00285	CcSEcCtD
Fluticasone Propionate—Mediastinal disorder—Temozolomide—melanoma	0.00092	0.00284	CcSEcCtD
Fluticasone Propionate—Malnutrition—Carmustine—melanoma	0.000919	0.00284	CcSEcCtD
Fluticasone Propionate—Erythema—Carmustine—melanoma	0.000919	0.00284	CcSEcCtD
Fluticasone Propionate—Cough—Bleomycin—melanoma	0.000919	0.00284	CcSEcCtD
Fluticasone Propionate—Ill-defined disorder—Dactinomycin—melanoma	0.000911	0.00281	CcSEcCtD
Fluticasone Propionate—Vomiting—Vemurafenib—melanoma	0.000902	0.00279	CcSEcCtD
Fluticasone Propionate—Chest pain—Bleomycin—melanoma	0.000897	0.00277	CcSEcCtD
Fluticasone Propionate—Rash—Vemurafenib—melanoma	0.000894	0.00276	CcSEcCtD
Fluticasone Propionate—Mental disorder—Temozolomide—melanoma	0.000894	0.00276	CcSEcCtD
Fluticasone Propionate—Dermatitis—Vemurafenib—melanoma	0.000894	0.00276	CcSEcCtD
Fluticasone Propionate—Headache—Vemurafenib—melanoma	0.000889	0.00274	CcSEcCtD
Fluticasone Propionate—Malnutrition—Temozolomide—melanoma	0.000888	0.00274	CcSEcCtD
Fluticasone Propionate—Erythema—Temozolomide—melanoma	0.000888	0.00274	CcSEcCtD
Fluticasone Propionate—Discomfort—Bleomycin—melanoma	0.000886	0.00274	CcSEcCtD
Fluticasone Propionate—Malaise—Dactinomycin—melanoma	0.000886	0.00273	CcSEcCtD
Fluticasone Propionate—Cramp muscle—Docetaxel—melanoma	0.000883	0.00273	CcSEcCtD
Fluticasone Propionate—Nasopharyngitis—Docetaxel—melanoma	0.000877	0.00271	CcSEcCtD
Fluticasone Propionate—Vision blurred—Carmustine—melanoma	0.000866	0.00268	CcSEcCtD
Fluticasone Propionate—Tremor—Carmustine—melanoma	0.000861	0.00266	CcSEcCtD
Fluticasone Propionate—Oedema—Bleomycin—melanoma	0.000859	0.00265	CcSEcCtD
Fluticasone Propionate—Anaphylactic shock—Bleomycin—melanoma	0.000859	0.00265	CcSEcCtD
Fluticasone Propionate—Infection—Bleomycin—melanoma	0.000854	0.00264	CcSEcCtD
Fluticasone Propionate—Agitation—Carmustine—melanoma	0.000845	0.00261	CcSEcCtD
Fluticasone Propionate—Nausea—Vemurafenib—melanoma	0.000843	0.0026	CcSEcCtD
Fluticasone Propionate—Vision blurred—Temozolomide—melanoma	0.000837	0.00259	CcSEcCtD
Fluticasone Propionate—Bronchospasm—Docetaxel—melanoma	0.000834	0.00258	CcSEcCtD
Fluticasone Propionate—Tremor—Temozolomide—melanoma	0.000832	0.00257	CcSEcCtD
Fluticasone Propionate—Discomfort—Dactinomycin—melanoma	0.000826	0.00255	CcSEcCtD
Fluticasone Propionate—Ill-defined disorder—Temozolomide—melanoma	0.000824	0.00255	CcSEcCtD
Fluticasone Propionate—Agitation—Temozolomide—melanoma	0.000816	0.00252	CcSEcCtD
Fluticasone Propionate—Angioedema—Temozolomide—melanoma	0.000812	0.00251	CcSEcCtD
Fluticasone Propionate—Oedema—Dactinomycin—melanoma	0.000802	0.00248	CcSEcCtD
Fluticasone Propionate—Malaise—Temozolomide—melanoma	0.000801	0.00247	CcSEcCtD
Fluticasone Propionate—Infection—Dactinomycin—melanoma	0.000796	0.00246	CcSEcCtD
Fluticasone Propionate—Hypertension—Carmustine—melanoma	0.000794	0.00245	CcSEcCtD
Fluticasone Propionate—Palpitations—Temozolomide—melanoma	0.000785	0.00242	CcSEcCtD
Fluticasone Propionate—Musculoskeletal discomfort—Bleomycin—melanoma	0.000783	0.00242	CcSEcCtD
Fluticasone Propionate—Chest pain—Carmustine—melanoma	0.000783	0.00242	CcSEcCtD
Fluticasone Propionate—Anxiety—Carmustine—melanoma	0.00078	0.00241	CcSEcCtD
Fluticasone Propionate—Cough—Temozolomide—melanoma	0.000775	0.00239	CcSEcCtD
Fluticasone Propionate—Hypertension—Temozolomide—melanoma	0.000767	0.00237	CcSEcCtD
Fluticasone Propionate—Dyspnoea—Bleomycin—melanoma	0.000766	0.00237	CcSEcCtD
Fluticasone Propionate—Pneumonia—Docetaxel—melanoma	0.00076	0.00235	CcSEcCtD
Fluticasone Propionate—Arthralgia—Temozolomide—melanoma	0.000756	0.00234	CcSEcCtD
Fluticasone Propionate—Infestation NOS—Docetaxel—melanoma	0.000756	0.00233	CcSEcCtD
Fluticasone Propionate—Infestation—Docetaxel—melanoma	0.000756	0.00233	CcSEcCtD
Fluticasone Propionate—Anxiety—Temozolomide—melanoma	0.000754	0.00233	CcSEcCtD
Fluticasone Propionate—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000751	0.00232	CcSEcCtD
Fluticasone Propionate—Oedema—Carmustine—melanoma	0.00075	0.00232	CcSEcCtD
Fluticasone Propionate—Discomfort—Temozolomide—melanoma	0.000747	0.00231	CcSEcCtD
Fluticasone Propionate—Infection—Carmustine—melanoma	0.000745	0.0023	CcSEcCtD
Fluticasone Propionate—Dry mouth—Temozolomide—melanoma	0.00074	0.00228	CcSEcCtD
Fluticasone Propionate—Pain—Bleomycin—melanoma	0.000735	0.00227	CcSEcCtD
Fluticasone Propionate—Conjunctivitis—Docetaxel—melanoma	0.000735	0.00227	CcSEcCtD
Fluticasone Propionate—Tachycardia—Carmustine—melanoma	0.000732	0.00226	CcSEcCtD
Fluticasone Propionate—Musculoskeletal discomfort—Dactinomycin—melanoma	0.00073	0.00226	CcSEcCtD
Fluticasone Propionate—Oedema—Temozolomide—melanoma	0.000725	0.00224	CcSEcCtD
Fluticasone Propionate—Anaphylactic shock—Temozolomide—melanoma	0.000725	0.00224	CcSEcCtD
Fluticasone Propionate—Infection—Temozolomide—melanoma	0.00072	0.00222	CcSEcCtD
Fluticasone Propionate—Epistaxis—Docetaxel—melanoma	0.000713	0.0022	CcSEcCtD
Fluticasone Propionate—Nervous system disorder—Temozolomide—melanoma	0.000711	0.0022	CcSEcCtD
Fluticasone Propionate—Feeling abnormal—Bleomycin—melanoma	0.000708	0.00219	CcSEcCtD
Fluticasone Propionate—Skin disorder—Temozolomide—melanoma	0.000704	0.00217	CcSEcCtD
Fluticasone Propionate—Pain—Dactinomycin—melanoma	0.000685	0.00212	CcSEcCtD
Fluticasone Propionate—Musculoskeletal discomfort—Carmustine—melanoma	0.000683	0.00211	CcSEcCtD
Fluticasone Propionate—Urticaria—Bleomycin—melanoma	0.000683	0.00211	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Bleomycin—melanoma	0.000679	0.0021	CcSEcCtD
Fluticasone Propionate—Hypoaesthesia—Docetaxel—melanoma	0.000675	0.00208	CcSEcCtD
Fluticasone Propionate—Pharyngitis—Docetaxel—melanoma	0.000673	0.00208	CcSEcCtD
Fluticasone Propionate—Dyspnoea—Carmustine—melanoma	0.000669	0.00207	CcSEcCtD
Fluticasone Propionate—Connective tissue disorder—Docetaxel—melanoma	0.000667	0.00206	CcSEcCtD
Fluticasone Propionate—Feeling abnormal—Dactinomycin—melanoma	0.00066	0.00204	CcSEcCtD
Fluticasone Propionate—Musculoskeletal discomfort—Temozolomide—melanoma	0.00066	0.00204	CcSEcCtD
Fluticasone Propionate—Gastrointestinal pain—Dactinomycin—melanoma	0.000655	0.00202	CcSEcCtD
Fluticasone Propionate—Dyspnoea—Temozolomide—melanoma	0.000646	0.002	CcSEcCtD
Fluticasone Propionate—Pain—Carmustine—melanoma	0.000642	0.00198	CcSEcCtD
Fluticasone Propionate—Eye disorder—Docetaxel—melanoma	0.000634	0.00196	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Dactinomycin—melanoma	0.000634	0.00196	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Dactinomycin—melanoma	0.000634	0.00196	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Bleomycin—melanoma	0.000633	0.00196	CcSEcCtD
Fluticasone Propionate—Cardiac disorder—Docetaxel—melanoma	0.00063	0.00194	CcSEcCtD
Fluticasone Propionate—Dexamethasone—CYP17A1—melanoma	0.000628	0.189	CrCbGaD
Fluticasone Propionate—Pain—Temozolomide—melanoma	0.00062	0.00191	CcSEcCtD
Fluticasone Propionate—Feeling abnormal—Carmustine—melanoma	0.000618	0.00191	CcSEcCtD
Fluticasone Propionate—Gastrointestinal pain—Carmustine—melanoma	0.000613	0.00189	CcSEcCtD
Fluticasone Propionate—Immune system disorder—Docetaxel—melanoma	0.000613	0.00189	CcSEcCtD
Fluticasone Propionate—Mediastinal disorder—Docetaxel—melanoma	0.000612	0.00189	CcSEcCtD
Fluticasone Propionate—Pruritus—Bleomycin—melanoma	0.000608	0.00188	CcSEcCtD
Fluticasone Propionate—Arrhythmia—Docetaxel—melanoma	0.000606	0.00187	CcSEcCtD
Fluticasone Propionate—Feeling abnormal—Temozolomide—melanoma	0.000597	0.00184	CcSEcCtD
Fluticasone Propionate—Mental disorder—Docetaxel—melanoma	0.000594	0.00184	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Carmustine—melanoma	0.000593	0.00183	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Carmustine—melanoma	0.000593	0.00183	CcSEcCtD
Fluticasone Propionate—Gastrointestinal pain—Temozolomide—melanoma	0.000593	0.00183	CcSEcCtD
Fluticasone Propionate—Erythema—Docetaxel—melanoma	0.000591	0.00182	CcSEcCtD
Fluticasone Propionate—Malnutrition—Docetaxel—melanoma	0.000591	0.00182	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Dactinomycin—melanoma	0.000591	0.00182	CcSEcCtD
Fluticasone Propionate—Urticaria—Temozolomide—melanoma	0.000576	0.00178	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Temozolomide—melanoma	0.000573	0.00177	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Temozolomide—melanoma	0.000573	0.00177	CcSEcCtD
Fluticasone Propionate—Muscle spasms—Docetaxel—melanoma	0.000568	0.00175	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Carmustine—melanoma	0.000553	0.00171	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Dactinomycin—melanoma	0.000548	0.00169	CcSEcCtD
Fluticasone Propionate—Vomiting—Bleomycin—melanoma	0.000546	0.00169	CcSEcCtD
Fluticasone Propionate—Rash—Bleomycin—melanoma	0.000542	0.00167	CcSEcCtD
Fluticasone Propionate—Dermatitis—Bleomycin—melanoma	0.000541	0.00167	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Temozolomide—melanoma	0.000534	0.00165	CcSEcCtD
Fluticasone Propionate—Palpitations—Docetaxel—melanoma	0.000522	0.00161	CcSEcCtD
Fluticasone Propionate—Cough—Docetaxel—melanoma	0.000515	0.00159	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Carmustine—melanoma	0.000513	0.00159	CcSEcCtD
Fluticasone Propionate—Pruritus—Temozolomide—melanoma	0.000513	0.00158	CcSEcCtD
Fluticasone Propionate—Dexamethasone—NOS2—melanoma	0.000512	0.154	CrCbGaD
Fluticasone Propionate—Nausea—Bleomycin—melanoma	0.00051	0.00158	CcSEcCtD
Fluticasone Propionate—Hypertension—Docetaxel—melanoma	0.00051	0.00157	CcSEcCtD
Fluticasone Propionate—Vomiting—Dactinomycin—melanoma	0.00051	0.00157	CcSEcCtD
Fluticasone Propionate—Rash—Dactinomycin—melanoma	0.000505	0.00156	CcSEcCtD
Fluticasone Propionate—Arthralgia—Docetaxel—melanoma	0.000503	0.00155	CcSEcCtD
Fluticasone Propionate—Chest pain—Docetaxel—melanoma	0.000503	0.00155	CcSEcCtD
Fluticasone Propionate—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000499	0.00154	CcSEcCtD
Fluticasone Propionate—Dizziness—Carmustine—melanoma	0.000496	0.00153	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Temozolomide—melanoma	0.000496	0.00153	CcSEcCtD
Fluticasone Propionate—Dry mouth—Docetaxel—melanoma	0.000492	0.00152	CcSEcCtD
Fluticasone Propionate—Anaphylactic shock—Docetaxel—melanoma	0.000482	0.00149	CcSEcCtD
Fluticasone Propionate—Oedema—Docetaxel—melanoma	0.000482	0.00149	CcSEcCtD
Fluticasone Propionate—Dizziness—Temozolomide—melanoma	0.000479	0.00148	CcSEcCtD
Fluticasone Propionate—Infection—Docetaxel—melanoma	0.000479	0.00148	CcSEcCtD
Fluticasone Propionate—Vomiting—Carmustine—melanoma	0.000477	0.00147	CcSEcCtD
Fluticasone Propionate—Nausea—Dactinomycin—melanoma	0.000476	0.00147	CcSEcCtD
Fluticasone Propionate—Rash—Carmustine—melanoma	0.000473	0.00146	CcSEcCtD
Fluticasone Propionate—Nervous system disorder—Docetaxel—melanoma	0.000473	0.00146	CcSEcCtD
Fluticasone Propionate—Dermatitis—Carmustine—melanoma	0.000473	0.00146	CcSEcCtD
Fluticasone Propionate—Tachycardia—Docetaxel—melanoma	0.000471	0.00145	CcSEcCtD
Fluticasone Propionate—Headache—Carmustine—melanoma	0.00047	0.00145	CcSEcCtD
Fluticasone Propionate—Skin disorder—Docetaxel—melanoma	0.000468	0.00145	CcSEcCtD
Fluticasone Propionate—Vomiting—Temozolomide—melanoma	0.000461	0.00142	CcSEcCtD
Fluticasone Propionate—Rash—Temozolomide—melanoma	0.000457	0.00141	CcSEcCtD
Fluticasone Propionate—Dermatitis—Temozolomide—melanoma	0.000457	0.00141	CcSEcCtD
Fluticasone Propionate—Headache—Temozolomide—melanoma	0.000454	0.0014	CcSEcCtD
Fluticasone Propionate—Nausea—Carmustine—melanoma	0.000446	0.00138	CcSEcCtD
Fluticasone Propionate—Musculoskeletal discomfort—Docetaxel—melanoma	0.000439	0.00136	CcSEcCtD
Fluticasone Propionate—Dexamethasone—CYP1B1—melanoma	0.000435	0.131	CrCbGaD
Fluticasone Propionate—Nausea—Temozolomide—melanoma	0.000431	0.00133	CcSEcCtD
Fluticasone Propionate—Dyspnoea—Docetaxel—melanoma	0.00043	0.00133	CcSEcCtD
Fluticasone Propionate—Pain—Docetaxel—melanoma	0.000412	0.00127	CcSEcCtD
Fluticasone Propionate—Feeling abnormal—Docetaxel—melanoma	0.000397	0.00123	CcSEcCtD
Fluticasone Propionate—Gastrointestinal pain—Docetaxel—melanoma	0.000394	0.00122	CcSEcCtD
Fluticasone Propionate—Fluticasone furoate—ABCB1—melanoma	0.00039	0.117	CrCbGaD
Fluticasone Propionate—Abdominal pain—Docetaxel—melanoma	0.000381	0.00118	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Docetaxel—melanoma	0.000381	0.00118	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Docetaxel—melanoma	0.000355	0.0011	CcSEcCtD
Fluticasone Propionate—Pruritus—Docetaxel—melanoma	0.000341	0.00105	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Docetaxel—melanoma	0.00033	0.00102	CcSEcCtD
Fluticasone Propionate—Dizziness—Docetaxel—melanoma	0.000319	0.000984	CcSEcCtD
Fluticasone Propionate—Methylprednisolone—ABCB1—melanoma	0.000311	0.0936	CrCbGaD
Fluticasone Propionate—Triamcinolone—PTGS2—melanoma	0.000308	0.0928	CrCbGaD
Fluticasone Propionate—Vomiting—Docetaxel—melanoma	0.000307	0.000947	CcSEcCtD
Fluticasone Propionate—Rash—Docetaxel—melanoma	0.000304	0.000939	CcSEcCtD
Fluticasone Propionate—Dermatitis—Docetaxel—melanoma	0.000304	0.000938	CcSEcCtD
Fluticasone Propionate—Headache—Docetaxel—melanoma	0.000302	0.000933	CcSEcCtD
Fluticasone Propionate—Nausea—Docetaxel—melanoma	0.000286	0.000884	CcSEcCtD
Fluticasone Propionate—Betamethasone—PTGS2—melanoma	0.000252	0.076	CrCbGaD
Fluticasone Propionate—Betamethasone—ABCB1—melanoma	0.000215	0.0646	CrCbGaD
Fluticasone Propionate—Dexamethasone—PTGS2—melanoma	0.000147	0.0442	CrCbGaD
Fluticasone Propionate—Dexamethasone—ABCB1—melanoma	0.000125	0.0376	CrCbGaD
Fluticasone Propionate—PGR—Signaling Pathways—SOCS1—melanoma	5.02e-05	0.000228	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—S100B—melanoma	5.01e-05	0.000227	CbGpPWpGaD
Fluticasone Propionate—PGR—Gene Expression—PPARG—melanoma	4.97e-05	0.000225	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism of lipids and lipoproteins—PTEN—melanoma	4.86e-05	0.00022	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—HDAC2—melanoma	4.86e-05	0.00022	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—FOXO4—melanoma	4.86e-05	0.00022	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CXCR4—melanoma	4.86e-05	0.00022	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—VEGFA—melanoma	4.82e-05	0.000219	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—GNAQ—melanoma	4.8e-05	0.000218	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—ERBB4—melanoma	4.79e-05	0.000217	CbGpPWpGaD
Fluticasone Propionate—NR3C2—Gene Expression—MAPK3—melanoma	4.78e-05	0.000217	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—NRAS—melanoma	4.76e-05	0.000216	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—CDKN2B—melanoma	4.75e-05	0.000215	CbGpPWpGaD
Fluticasone Propionate—NR3C2—Gene Expression—MYC—melanoma	4.65e-05	0.000211	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—PIK3CG—melanoma	4.63e-05	0.00021	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—UGT2B10—melanoma	4.6e-05	0.000209	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—CD86—melanoma	4.59e-05	0.000208	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—MAPK3—melanoma	4.56e-05	0.000207	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—CYP17A1—melanoma	4.56e-05	0.000207	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—EDN1—melanoma	4.56e-05	0.000207	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—ABCB1—melanoma	4.53e-05	0.000206	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—SYK—melanoma	4.51e-05	0.000205	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—CSF2—melanoma	4.45e-05	0.000202	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—FGF1—melanoma	4.45e-05	0.000202	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—ITGAV—melanoma	4.43e-05	0.000201	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—AKT3—melanoma	4.43e-05	0.000201	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—NGFR—melanoma	4.43e-05	0.000201	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—E2F1—melanoma	4.36e-05	0.000198	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—PLA2G6—melanoma	4.35e-05	0.000197	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—MAPK1—melanoma	4.34e-05	0.000197	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—PDGFRA—melanoma	4.31e-05	0.000196	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—GNA11—melanoma	4.3e-05	0.000195	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—HS3ST5—melanoma	4.27e-05	0.000194	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—ITGB3—melanoma	4.27e-05	0.000194	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—PRKCA—melanoma	4.27e-05	0.000194	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—CDKN2B—melanoma	4.22e-05	0.000192	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—FASN—melanoma	4.21e-05	0.000191	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—SPP1—melanoma	4.19e-05	0.00019	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—MAP2K2—melanoma	4.17e-05	0.000189	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—PRKCA—melanoma	4.17e-05	0.000189	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—SLC5A5—melanoma	4.14e-05	0.000188	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—ERCC2—melanoma	4.14e-05	0.000188	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—VDR—melanoma	4.12e-05	0.000187	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—SOCS1—melanoma	4.1e-05	0.000186	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—KRAS—melanoma	4.1e-05	0.000186	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—MAP2K1—melanoma	4.09e-05	0.000186	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—S100B—melanoma	4.09e-05	0.000186	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—PIK3CD—melanoma	4.07e-05	0.000185	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—CD44—melanoma	4e-05	0.000182	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—GNAQ—melanoma	4e-05	0.000182	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—TERT—melanoma	3.97e-05	0.00018	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—RAC1—melanoma	3.96e-05	0.00018	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—ERBB4—melanoma	3.91e-05	0.000178	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—VCAN—melanoma	3.91e-05	0.000177	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CDKN2B—melanoma	3.88e-05	0.000176	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—CYP1B1—melanoma	3.84e-05	0.000174	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—HIF1A—melanoma	3.8e-05	0.000172	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—PRKCA—melanoma	3.8e-05	0.000172	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—ERCC2—melanoma	3.77e-05	0.000171	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—PIK3CA—melanoma	3.77e-05	0.000171	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CD86—melanoma	3.75e-05	0.00017	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—EDN1—melanoma	3.72e-05	0.000169	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—TP53—melanoma	3.64e-05	0.000165	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CSF2—melanoma	3.64e-05	0.000165	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—FGF1—melanoma	3.64e-05	0.000165	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—KDR—melanoma	3.63e-05	0.000165	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—E2F1—melanoma	3.56e-05	0.000162	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—PIK3CB—melanoma	3.54e-05	0.000161	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—PDGFRA—melanoma	3.52e-05	0.00016	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—FN1—melanoma	3.5e-05	0.000159	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—ITGB3—melanoma	3.49e-05	0.000158	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—PRKCA—melanoma	3.49e-05	0.000158	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—HRAS—melanoma	3.48e-05	0.000158	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	3.43e-05	0.000156	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—SPP1—melanoma	3.42e-05	0.000155	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—NOTCH1—melanoma	3.42e-05	0.000155	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—MAP2K2—melanoma	3.41e-05	0.000155	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—CXCL8—melanoma	3.41e-05	0.000155	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Generic Transcription Pathway—MYC—melanoma	3.4e-05	0.000154	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—CD80—melanoma	3.35e-05	0.000152	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—PIK3CG—melanoma	3.35e-05	0.000152	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—KIT—melanoma	3.35e-05	0.000152	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—APC—melanoma	3.35e-05	0.000152	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—EGF—melanoma	3.31e-05	0.00015	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—CYP17A1—melanoma	3.29e-05	0.000149	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—PIK3CG—melanoma	3.27e-05	0.000148	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—IL2—melanoma	3.26e-05	0.000148	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—TERT—melanoma	3.24e-05	0.000147	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PLCB4—melanoma	3.24e-05	0.000147	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—RAC1—melanoma	3.23e-05	0.000147	CbGpPWpGaD
Fluticasone Propionate—NR3C2—Gene Expression—AKT1—melanoma	3.22e-05	0.000146	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—ABCB1—melanoma	3.16e-05	0.000143	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—PPARG—melanoma	3.15e-05	0.000143	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—BRAF—melanoma	3.14e-05	0.000143	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—GNA11—melanoma	3.11e-05	0.000141	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—HIF1A—melanoma	3.1e-05	0.000141	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—AKT1—melanoma	3.08e-05	0.00014	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—IGF1—melanoma	3.06e-05	0.000139	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—SLC6A11—melanoma	3.04e-05	0.000138	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PIP4K2A—melanoma	3.04e-05	0.000138	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—FASN—melanoma	3.04e-05	0.000138	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—NOTCH1—melanoma	3.04e-05	0.000138	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—SLC5A5—melanoma	3e-05	0.000136	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—KDR—melanoma	2.97e-05	0.000135	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—MTAP—melanoma	2.96e-05	0.000134	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—MAP2K1—melanoma	2.96e-05	0.000134	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—PIK3CD—melanoma	2.94e-05	0.000133	CbGpPWpGaD
Fluticasone Propionate—PGR—Gene Expression—MAPK3—melanoma	2.91e-05	0.000132	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—PRKCA—melanoma	2.91e-05	0.000132	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—CD44—melanoma	2.89e-05	0.000131	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—GNAQ—melanoma	2.89e-05	0.000131	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—ERCC2—melanoma	2.88e-05	0.000131	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—PIK3CD—melanoma	2.87e-05	0.00013	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—PPARG—melanoma	2.87e-05	0.00013	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—FN1—melanoma	2.86e-05	0.00013	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—ALB—melanoma	2.84e-05	0.000129	CbGpPWpGaD
Fluticasone Propionate—PGR—Gene Expression—MYC—melanoma	2.83e-05	0.000128	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—FGF2—melanoma	2.82e-05	0.000128	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—NOTCH1—melanoma	2.79e-05	0.000127	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—CYP1B1—melanoma	2.77e-05	0.000126	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CD80—melanoma	2.74e-05	0.000124	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—PIK3CG—melanoma	2.73e-05	0.000124	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—APC—melanoma	2.73e-05	0.000124	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—KIT—melanoma	2.73e-05	0.000124	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—NRAS—melanoma	2.73e-05	0.000124	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—EGF—melanoma	2.7e-05	0.000123	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PHGDH—melanoma	2.64e-05	0.00012	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—LUM—melanoma	2.64e-05	0.00012	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—MDM2—melanoma	2.63e-05	0.00012	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—MAPK3—melanoma	2.62e-05	0.000119	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—ERBB2—melanoma	2.6e-05	0.000118	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—HPSE—melanoma	2.59e-05	0.000117	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—BRAF—melanoma	2.57e-05	0.000117	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—PIK3CB—melanoma	2.56e-05	0.000116	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—CUBN—melanoma	2.54e-05	0.000115	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—PIK3CB—melanoma	2.5e-05	0.000114	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—IGF1—melanoma	2.5e-05	0.000114	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—MAPK1—melanoma	2.49e-05	0.000113	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—EGFR—melanoma	2.49e-05	0.000113	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—PTGS2—melanoma	2.48e-05	0.000113	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—CXCL8—melanoma	2.46e-05	0.000112	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—SDHD—melanoma	2.45e-05	0.000111	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—BSG—melanoma	2.45e-05	0.000111	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—CSPG4—melanoma	2.45e-05	0.000111	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—MAP2K1—melanoma	2.42e-05	0.00011	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—CDKN1B—melanoma	2.41e-05	0.000109	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—PIK3CD—melanoma	2.4e-05	0.000109	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—GPAM—melanoma	2.38e-05	0.000108	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—CASP3—melanoma	2.36e-05	0.000107	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—IL2—melanoma	2.35e-05	0.000107	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—KRAS—melanoma	2.35e-05	0.000107	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—FGF2—melanoma	2.3e-05	0.000104	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—CCND1—melanoma	2.29e-05	0.000104	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—ABCB1—melanoma	2.28e-05	0.000104	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—PIK3CG—melanoma	2.28e-05	0.000103	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—CTNNB1—melanoma	2.27e-05	0.000103	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—MMP9—melanoma	2.23e-05	0.000101	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—CDKN1A—melanoma	2.22e-05	0.000101	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—PTEN—melanoma	2.21e-05	0.0001	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—NFKB1—melanoma	2.2e-05	0.0001	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—PPARG—melanoma	2.2e-05	9.97e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—PTEN—melanoma	2.16e-05	9.82e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—PIK3CA—melanoma	2.16e-05	9.8e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—MDM2—melanoma	2.15e-05	9.76e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—ERBB2—melanoma	2.12e-05	9.63e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—PRKCA—melanoma	2.1e-05	9.54e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—PIK3CB—melanoma	2.09e-05	9.5e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—ERCC2—melanoma	2.08e-05	9.46e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PLA2G6—melanoma	2.02e-05	9.17e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CXCL8—melanoma	2.01e-05	9.13e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—PIK3CD—melanoma	2e-05	9.08e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—VEGFA—melanoma	2e-05	9.08e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—HRAS—melanoma	2e-05	9.07e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—STAT3—melanoma	1.98e-05	8.99e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—ALB—melanoma	1.98e-05	8.97e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—NRAS—melanoma	1.98e-05	8.97e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CDKN1B—melanoma	1.96e-05	8.92e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Gene Expression—AKT1—melanoma	1.96e-05	8.91e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CASP3—melanoma	1.93e-05	8.74e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—IL2—melanoma	1.92e-05	8.73e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—IL6—melanoma	1.91e-05	8.68e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—MAPK3—melanoma	1.89e-05	8.59e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CCND1—melanoma	1.87e-05	8.51e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CTNNB1—melanoma	1.86e-05	8.42e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—MYC—melanoma	1.84e-05	8.35e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—MMP9—melanoma	1.82e-05	8.26e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—VCAN—melanoma	1.82e-05	8.24e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CDKN1A—melanoma	1.81e-05	8.23e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—PTEN—melanoma	1.81e-05	8.21e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—MAPK1—melanoma	1.8e-05	8.17e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—NFKB1—melanoma	1.8e-05	8.17e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—EGFR—melanoma	1.8e-05	8.17e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—AKT1—melanoma	1.77e-05	8.01e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—PIK3CB—melanoma	1.75e-05	7.92e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—PTGS2—melanoma	1.73e-05	7.85e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—KRAS—melanoma	1.7e-05	7.72e-05	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—MAPK3—melanoma	1.68e-05	7.63e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—PIK3CG—melanoma	1.65e-05	7.47e-05	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—MYC—melanoma	1.64e-05	7.42e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—VEGFA—melanoma	1.63e-05	7.42e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—STAT3—melanoma	1.62e-05	7.34e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—NRAS—melanoma	1.61e-05	7.32e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—PPARG—melanoma	1.59e-05	7.21e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—PIK3CA—melanoma	1.56e-05	7.09e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—MAPK3—melanoma	1.55e-05	7.01e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—CYP17A1—melanoma	1.53e-05	6.95e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—PIK3CA—melanoma	1.53e-05	6.93e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—TP53—melanoma	1.51e-05	6.86e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—PTEN—melanoma	1.51e-05	6.84e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—MYC—melanoma	1.5e-05	6.82e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—MAPK1—melanoma	1.47e-05	6.67e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—EGFR—melanoma	1.47e-05	6.67e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—PIK3CD—melanoma	1.45e-05	6.57e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—GNA11—melanoma	1.45e-05	6.56e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—HRAS—melanoma	1.45e-05	6.56e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—ALB—melanoma	1.43e-05	6.48e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—FASN—melanoma	1.42e-05	6.42e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—SLC5A5—melanoma	1.39e-05	6.32e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—KRAS—melanoma	1.39e-05	6.3e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—IL6—melanoma	1.38e-05	6.28e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—GNAQ—melanoma	1.34e-05	6.1e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—CD44—melanoma	1.34e-05	6.1e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—CYP1B1—melanoma	1.29e-05	5.85e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—AKT1—melanoma	1.28e-05	5.79e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—PIK3CA—melanoma	1.28e-05	5.79e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—PIK3CB—melanoma	1.26e-05	5.72e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—PTGS2—melanoma	1.25e-05	5.67e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—AKT1—melanoma	1.25e-05	5.66e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—TP53—melanoma	1.23e-05	5.6e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—HRAS—melanoma	1.18e-05	5.36e-05	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—AKT1—melanoma	1.13e-05	5.15e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—IL6—melanoma	1.13e-05	5.13e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—PTEN—melanoma	1.09e-05	4.95e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—PIK3CA—melanoma	1.06e-05	4.83e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—ABCB1—melanoma	1.06e-05	4.82e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—AKT1—melanoma	1.04e-05	4.73e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PRKCA—melanoma	9.77e-06	4.43e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—ERCC2—melanoma	9.69e-06	4.4e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—AKT1—melanoma	8.69e-06	3.94e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—PIK3CA—melanoma	7.69e-06	3.49e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PIK3CG—melanoma	7.65e-06	3.47e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PPARG—melanoma	7.39e-06	3.35e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PIK3CD—melanoma	6.73e-06	3.05e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—ALB—melanoma	6.64e-06	3.01e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—AKT1—melanoma	6.28e-06	2.85e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PIK3CB—melanoma	5.86e-06	2.66e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PTGS2—melanoma	5.81e-06	2.64e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PTEN—melanoma	5.07e-06	2.3e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PIK3CA—melanoma	3.57e-06	1.62e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—AKT1—melanoma	2.92e-06	1.33e-05	CbGpPWpGaD
